Fish-Derived Collagen Peptide Promotes Hair Growth by Activating a Key Hair Follicle Pathway

Low molecular weight collagen peptide (LMWCP) from fish promoted hair growth across multiple experimental models: it stimulated human dermal papilla cell proliferation and mitochondrial activity, increased secretion of growth factors (EGF, HB-EGF, FGF-4, FGF-6), boosted new hair follicle formation in a dose-dependent manner in patch assays, promoted human hair follicle growth ex vivo, and significantly stimulated hair growth when given orally to mice. The mechanism involved activation of the Wnt/GSK-3β/β-catenin signaling pathway, with upregulation of Wnt3a, β-catenin, VEGF, PCNA, Cyclin D1, and hair-specific keratins.

Multi-model study: (1) In vitro testing on human dermal papilla cells (hDPCs) measuring proliferation, mitochondrial activity, and growth factor secretion; (2) Patch assay for hair follicle neogeneration; (3) Ex vivo human hair follicle growth assessment; (4) In vivo oral administration to telogenic C57BL/6 mice with histological and molecular analysis of back skin. Wnt/β-catenin pathway activation was confirmed through protein expression and nuclear translocation studies.

Hair loss affects hundreds of millions of people worldwide, yet treatment options are limited (mainly minoxidil and finasteride). Collagen peptides are widely available as supplements and generally well-tolerated. If these preclinical results translate to humans, oral collagen peptide supplements could provide a new, accessible approach to promoting hair growth through a well-characterized molecular pathway (Wnt/β-catenin) that is central to hair follicle biology.

The Wnt/β-catenin pathway is recognized as one of the most important regulators of hair follicle biology — when active, it drives hair growth; when suppressed, hair enters the resting phase. Finding that an orally administered collagen peptide can activate this pathway is significant because most Wnt-targeting approaches in hair loss research require topical application or genetic manipulation. Collagen peptide supplements are already popular for skin and joint health, and this research could expand their applications to hair growth.

While multiple models were used, the study is preclinical — no human clinical trial of oral LMWCP for hair growth was conducted. The mouse model (telogenic C57BL/6) tests hair cycle re-entry rather than reversal of actual hair loss conditions like androgenetic alopecia. The fish-derived collagen peptide composition may vary between sources and batches. Oral bioavailability of the specific active peptide fractions is not fully characterized.